Plasma Derived Medicine Market Report 2025 (Global Edition)

Global Plasma Derived Medicine Market Report 2025 Market Size Split by Product Type (Albumin, Coagulation factors, Immunoglobulins, Others), by Indication (Pelvic Inflammatory Disease (PID), Bleeding ...

Plasma Derived Medicine Market Report Description

We have various report editions of Plasma Derived Medicine Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Plasma Derived Medicine Market Insights Video

Competitive Landscape of the Plasma Derived Medicine Market

The plasma-derived medication marketplace functions severe opposition among key gamers, along with Grifols, CSL Behring, and Takeda Pharmaceutical Company. These organizations compete thru strategies inclusive of product innovation, strategic alliances, and geographical expansion. Additionally, stringent regulatory necessities and the want for continuous technological improvements similarly intensify competition in this dynamic market, riding businesses to distinguish themselves primarily based on product quality and safety.

Top Companies Market Share in Plasma Derived Medicine Industry: (In no particular order of Rank)

• Grifols
• S A
• SK Plasma
• Fusion Healthcare
• Takeda Pharmaceutical Company Limited
• LFB
• Octapharma AG
• CSL Limited
• Bio Products Laboratory Ltd
• China Biologic Products Holdings
• Kedrion
• Shanghai RAAS
• ADMA Biologics Inc
• Kamada Pharmaceuticals
• Biotest AG
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of Plasma Derived Medicine Market

Which Region Dominates the Plasma Derived Medicine Market in 2024?

According to Cognitive Market Research, North America dominated the market in 2024 and accounted for around 40% of the global revenue. In North America, the Plasma Derived Medicine Market is robust and exceptionally regulated, with the United States and Canada being the primary participants. The place boasts superior healthcare infrastructure, rigorous quality standards, and a large patient population, riding vast calls for plasma-derived products. The presence of key pharmaceutical businesses and leading studies institutions, in addition, propels marketplace boom through innovation and product improvement. Additionally, favorable reimbursement regulations and increasing awareness about plasma-derived therapies among healthcare professionals and patients contribute to marketplace enlargement. However, regulatory requirements and compliance standards pose demanding situations for market entry. Overall, North America remains a pivotal place inside the global plasma-derived medicine marketplace, characterised by way of sustained boom and advancements in healing interventions.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific vicinity, the Plasma Derived Medicine Market famous significant potential driven by the aid of elements inclusive of growing healthcare expenditure, growing consciousness about plasma-derived therapies, and rising prevalence of persistent sicknesses. Countries like China, India, Japan, and South Korea are key participants in market growth due to their large population bases and expanding healthcare infrastructure. Additionally, favorable authorities initiatives geared toward improving healthcare get right of entry and affordability are in addition fueling market expansion. However, challenges inclusive of regulatory complexities and infrastructure boundaries in some regions might also hinder market increase. Overall, the Asia-Pacific region offers beneficial opportunities for market players to put money into research, development, and distribution networks to fulfill the growing demand for plasma-derived drugs.

The current report Scope analyzes Plasma Derived Medicine Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Plasma Derived Medicine

According to Cognitive Market Research, the global Plasma Derived Medicine Market size was estimated at USD 31515.2 Million, out of which North America held the major market of more than 40% of the global revenue with a market size of USD 12606.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Plasma-Derived Medicine Market, with a market size of USD 9946.20 million in 2024, and it is projected to grow at a CAGR of 5.0% during the forecast period. Advances in healthcare infrastructure and rising healthcare expenditures contribute to greater accessibility and adoption of these medicines.
• The Canada Plasma-Derived Medicine Market had a market share of USD 1512.73 million in 2024 and is projected to grow at a CAGR of 6.0% during the forecast period. Key market players' investments in research and development activities also fuel growth.
• The Mexico Plasma Derived Medicine Market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 1147.15 million in 2024.

Europe Plasma Derived Medicine

According to Cognitive Market Research,  the global Plasma Derived Medicine Market size was estimated at USD 31515.2 Million, out of which Europe held the market of more than 30% of the global revenue with a market size of USD 9454.56 million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2031.

• The United Kingdom Plasma Derived Medicine Market had a market share of USD 1588.37 million in 2024 and is projected to grow at a CAGR of 6.3% during the forecast period. In the UK, government initiatives and healthcare policies promoting access to essential medicines support market growth by ensuring broader patient access to plasma-derived therapies.
• The France Plasma Derived Medicine Market is projected to witness growth at a CAGR of 4.7% during the forecast period, with a market size of USD 869.82 million in 2024.
• According to Cognitive Market Research, the German plasma-derived Medicine Market was valued at USD 1872.00 million in 2024 and is projected to grow at a CAGR of 5.7% during the forecast period. Germany is a leader in medical research and innovation, so there's a strong emphasis on developing and adopting cutting-edge plasma-derived treatments.
• The Italy Plasma-Derived Medicine Market is projected to grow at a CAGR of 4.9% during the forecast period, reaching a market size of USD 813.09 million in 2024.
• The Russian plasma-derived Medicine Market is projected to grow at a CAGR of 4.5 % during the forecast period, reaching a market size of USD 1465.46 million in 2024.
• The Spanish plasma Medicine Market is projected to grow at a CAGR of 4.6% during the forecast period, reaching a market size of USD 775.27 million in 2024.
• The Luxembourg Plasma Derived Medicine Market is projected to witness growth at a CAGR of 5.6% during the forecast period, with a market size of USD 293.09 million in 2024.
• The Portugal Plasma-Derived Medicine Market is projected to grow at a CAGR of 5.3% during the forecast period, reaching a market size of USD 198.55 million in 2024.
• The Greece Plasma Medicine Market is projected to grow at a CAGR of 5.8% during the forecast period, reaching a market size of USD 113.45 million in 2024.
• The rest of Europe's derived Medicine Market is projected to witness growth at a CAGR of 4.2% during the forecast period, with a market size of USD 1465.46 million in 2024

Asia Pacific Plasma Derived Medicine

According to Cognitive Market Research, the global Plasma Derived Medicine Market size was estimated at USD 31515.2 Million, out of which Asia Pacific held the market of around 23% of the global revenue with a market size of USD 7248.50 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.0% from 2024 to 2031.

• According to Cognitive Market Research, the China Plasma-Derived Medicine Market was valued at USD 3267.82 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. Plasma-derived medicine regulatory reforms aimed at streamlining approval processes and enhancing drug quality standards enhance investor confidence and encourage investment in the plasma-derived medicine sector.
• The Japan Plasma-Derived Medicine Market is projected to grow at a CAGR of 7.5% during the forecast period, reaching a market size of USD 1000.29 million in 2024.
• The India Plasma Derived Medicine Market had a market share of USD 869.82 million in 2024 and is projected to grow at a CAGR of 10.8% during the forecast period. The rising investments in research and development activities aimed at expanding the therapeutic applications of plasma-derived products contribute to market growth.
• The South Korean plasma-derived Medicine Market is projected to grow at a CAGR of 8.1% during the forecast period, reaching a market size of USD 724.85 million in 2024.
• The Australian Plasma-Derived Medicine Market is projected to grow at a CAGR of 8.7% during the forecast period, reaching a market size of USD 376.92 million in 2024.
• The South East Asia Plasma-Derived Medicine Market is projected to grow at a CAGR of 10.0% during the forecast period, reaching a market size of USD 500.15 million in 2024.
• The Rest of the Asia Pacific Plasma Derived Medicine Market is projected to witness growth at a CAGR of 8.8% during the forecast period, with a market size of USD 514.64 million in 2024.

South America Plasma Derived Medicine

According to Cognitive Market Research, the global Plasma Derived Medicine Market size was estimated at USD 31515.2 Million, out of which Latin America market of more than 5% of the global revenue with a market size of USD 1575.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Plasma Derived Medicine Market size was valued at USD 674.43 million in 2024 and is projected to grow at a CAGR of 7.0% during the forecast period. Plasma Medicine advancements in healthcare infrastructure and technology enhance the production and distribution capabilities of plasma-derived medicines, improving accessibility across diverse regions of Brazil.
• The Argentina Plasma Derived Medicine Market had a market share of USD 264.73 million in 2024 and is projected to grow at a CAGR of 7.3% during the forecast period. The presence of established pharmaceutical companies investing in research and development activities also contributes to market expansion by introducing innovative plasma-derived products tailored to meet the specific needs of the Argentine population.
• The Colombia Plasma Derived Medicine Market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 140.24 million in 2024.
• The Peru Plasma-Derived Medicine Market is projected to grow at a CAGR of 6.6% during the forecast period, reaching a market size of USD 129.21 million in 2024.
• The Chile Plasma-Derived Medicine Market is projected to grow at a CAGR of 6.7% during the forecast period, reaching a market size of USD 113.45 million in 2024.
• The Rest of the Latin America-derived Medicine Market is projected to witness growth at a CAGR of 5.5% during the forecast period, with a market size of USD 253.70 million in 2024

Middle East and Africa Plasma Derived Medicine

According to Cognitive Market Research, the global Plasma Derived Medicine Market size was estimated at USD 31515.2 Million, out of which the Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 630.30 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

• The GCC Countries' Plasma-Derived Medicine Market is projected to witness growth at a CAGR of 7.5% during the forecast period, with a market size of USD 269.77 million in 2024. Plasma Plasma-derived medicine's expanding elderly population in the GCC nations, coupled with a higher incidence of age-related conditions, drives the need for plasma-derived medicines.
• The Egypt Plasma-Derived Medicine Market is projected to grow at a CAGR of 7.0% during the forecast period, reaching a market size of USD 66.18 million in 2024.
• The South African Plasma-Derived Medicine Market is projected to grow at a CAGR of 7.7% during the forecast period, reaching a market size of USD 99.59 million in 2024. The country's evolving healthcare infrastructure, coupled with a growing prevalence of chronic diseases, fuels the demand for plasma-derived medicines.
• The Turkey Plasma-Derived Medicine Market is projected to grow at a CAGR of 6.2% during the forecast period, reaching a market size of USD 54.21 million in 2024.
• The Nigeria Plasma-Derived Medicine Market is projected to grow at a CAGR of 5.8% during the forecast period, reaching a market size of USD 66.18 million in 2024.
• The Rest of the MEA Plasma Derived Medicine Market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 74.38 million in 2024

Plasma Derived Medicine Market Analysis

Plasma Derived Medicine Market Product Type Segment Analysis

Albumin, a key thing of blood plasma, is mostly used to treat situations like shock, burns, liver disorders, and severe infections. It facilitates to hold blood quantity and stress, making it vital in vital care settings. Additionally, albumin treatment plans are applied in conditions wherein protein loss is big, along with in sure renal problems.

Coagulation factors, then again, are crucial proteins involved in the blood clotting system. These elements are critical for people with hemophilia or different clotting problems. They are frequently administered to save you or forestall bleeding episodes, improving the pleasantness of existence for the ones affected.

• Albumin 
• Coagulation factors 
• Immunoglobulins 
• Others

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Plasma Derived Medicine Industry. Request a Free Sample PDF!

Plasma Derived Medicine Market Indication Segment Analysis

PID, a massive segment, refers to irritation of the woman's reproductive organs, in general, caused by bacterial infection. Plasma-derived therapies play an important position in dealing with PID-associated complications, offering immunoglobulins to combat infectious marketers and reduce irritation, thereby aiding in symptom relief and promoting healing.

Bleeding disorders represent any other pivotal section, encompassing conditions like hemophilia and von Willebrand ailment. Plasma-derived clotting factors are vital for individuals with those problems, as they lack the essential proteins to facilitate everyday blood clotting. These treatments provide the lacking factors, allowing powerful hemostasis and minimizing the danger of bleeding episodes, thereby enhancing sufferers' exceptional lifestyles and decreasing morbidity and mortality.

• Pelvic Inflammatory Disease (PID) 
• Bleeding Disorders 
• Alpha-1 Antitrypsin Deficiency (AATD) 
• Hereditary Angioedema (HAE) 
• Chronic Inflammatory Demyelinating Polyneuropathy 
• Guillain-Barre Syndrome 
• Multifocal Motor Neuropathy 
• Liver Diseases 
• Primary Immune Thrombocytopenia 
• Infections 
• Other Orphan Diseases

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Plasma Derived Medicine Distribution Channel Segment Analysis

Hospital Pharmacies: As important hubs within healthcare establishments, health facility pharmacies are integral in handling and doling out plasma-derived drugs to patients and presenting process remedies inside the hospital setting. These pharmacies regularly have specialized infrastructure and employees trained to deal with complex medicines, ensuring sure right administration and patient protection. They serve as an instantaneous link among healthcare providers and sufferers, imparting customized care and steering concerning medicinal drug usage and capability side outcomes.

Retail pharmacies: In contrast, retail pharmacies serve a broader demographic; providing patients with access to plasma-derived medicines for chronic or curative conditions so outside the hospital makes it convenient and accessible, allowing patients to refill prescriptions and get the medicines they need closer to home Pharmacies that sell drugs can also provide counseling services, educating patients medication use and compliance.

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Author's Detail

Manjiri Kanhere

Senior Research Associate at Cognitive Market Research

LinkedIn

Profile

Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.

Author's Conclusion